Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,672 | -65,478 | N/A | N/A | N/A |
| Depreciation Amortization | 6,949 | 30,507 | N/A | N/A | N/A |
| Accounts receivable | -650 | 6,399 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -5,569 | 1,292 | N/A | N/A | N/A |
| Other Working Capital | -17,694 | 50,207 | N/A | N/A | N/A |
| Other Operating Activity | 8,060 | -21,051 | -34,159 | -9,288 | -6,711 |
| Operating Cash Flow | $-10,576 | $1,876 | $-34,159 | $-9,288 | $-6,711 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15,476 | 24,782 | 16,816 | 26,028 | -60 |
| PPE Investments | -222 | -1,479 | -1,033 | -864 | -113 |
| Purchase Of Investment | N/A | -3,790 | -40 | N/A | N/A |
| Sale Of Investment | 1,094 | 2,177 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -702 | -3,691 | -2,779 | -1,592 | -349 |
| Other Investing Activity | -702 | -3,691 | -2,779 | -1,592 | -349 |
| Investing Cash Flow | $-15,306 | $17,999 | $12,964 | $23,572 | $-522 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 203,797 | 203,789 | 9,100 | N/A |
| Debt Repayment | -2,773 | -174,137 | -171,297 | -4,833 | -2,491 |
| Common Stock Issued | 11,823 | 9,470 | 7,789 | 1,617 | 638 |
| Financing Cash Flow | $9,050 | $39,130 | $40,281 | $5,884 | $-1,853 |
| Beginning Cash Position | 124,482 | 65,477 | 65,477 | 65,477 | 65,477 |
| End Cash Position | 107,650 | 124,482 | 84,563 | 85,645 | 56,391 |
| Net Cash Flow | $-16,832 | $59,005 | $19,086 | $20,168 | $-9,086 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,576 | 1,876 | -34,159 | -9,288 | -6,711 |
| Capital Expenditure | -222 | -1,479 | -1,033 | -864 | -113 |
| Free Cash Flow | -10,798 | 397 | -35,192 | -10,152 | -6,824 |